首页> 外文期刊>细胞研究(英文版) >Phosphorylation of glutaminase by PKCε is essential for its enzymatic activity and critically contributes to tumorigenesis
【24h】

Phosphorylation of glutaminase by PKCε is essential for its enzymatic activity and critically contributes to tumorigenesis

机译:PKCε对谷氨酰胺酶进行磷酸化对其酶活性至关重要,并在肿瘤发生中起关键作用

获取原文
获取原文并翻译 | 示例
       

摘要

Glutamine metabolism plays an important role in cancer development and progression.Glutaminase C (GAC),the first enzyme in glutaminolysis,has emerged as an important target for cancer therapy and many studies have focused on the mechanism of enhanced GAC expression in cancer cells.However,little is known about the post-translational modification of GAC.Here,we report that phosphorylation is a crucial post-translational modification of GAC,which is responsible for the higher glutaminase activity in lung tumor tissues and cancer cells.We identify the key Ser314 phosphorylation site on GAC that is regulated by the NF-KB-PKCε axis.Blocking Ser314 phosphorylation by the S314A mutation in lung cancer cells inhibits the glutaminase activity,triggers genetic reprogramming,and alleviates tumor malignancy.Furthermore,we find that a high level of GAC phosphorylation correlates with poor survival rate of lung cancer patients.These findings highlight a previously unappreciated mechanism for activation of GAC by phosphorylation and demonstrate that targeting glutaminase activity can inhibit oncogenic transformation.
机译:谷氨酰胺代谢在癌症的发展和发展中起着重要作用。谷氨酰胺酶C(GAC)是谷氨酰胺分解中的第一种酶,已成为癌症治疗的重要靶标,许多研究都集中在癌细胞中GAC表达增强的机制上。 ,我们对GAC的翻译后修饰了解甚少。在此,我们报道磷酸化是GAC的重要翻译后修饰,它负责肺肿瘤组织和癌细胞中更高的谷氨酰胺酶活性。我们确定了关键的Ser314 GAC上的磷酸化位点受NF-KB-PKCε轴调控。S314A突变可阻断肺癌细胞中的Ser314磷酸化,抑制谷氨酰胺酶活性,触发基因重编程,并减轻肿瘤恶性程度。此外,我们发现高水平的GAC磷酸化与肺癌患者生存率低相关,这些发现突出了以前未被认识的激活机制磷酸化GAC离子,并证明靶向谷氨酰胺酶活性可以抑制致癌转化。

著录项

  • 来源
    《细胞研究(英文版)》 |2018年第6期|655-669|共15页
  • 作者单位

    Institute of Translational Medicine, Nanchang University, Nanchang City, Jiangxi 330031, China;

    School of Life Sciences, Nanchang University, Nanchang City, Jiangxi 330031, China;

    Institute of Translational Medicine, Nanchang University, Nanchang City, Jiangxi 330031, China;

    School of Life Sciences, Nanchang University, Nanchang City, Jiangxi 330031, China;

    Institute of Translational Medicine, Nanchang University, Nanchang City, Jiangxi 330031, China;

    Department of Pathology, The Second Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi 330006, China;

    Department of Cardiovascular Surgery, The First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi 330006, China;

    Institute of Health Sciences, Chinese Academy of Sciences at Shanghai, Shanghai 200025, China;

    Institute of Translational Medicine, Nanchang University, Nanchang City, Jiangxi 330031, China;

  • 收录信息 中国科学引文数据库(CSCD);中国科技论文与引文数据库(CSTPCD);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 04:01:41
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号